Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2005, Vol. 10 ›› Issue (9): 1015-1024.

Previous Articles     Next Articles

Study on mechanisms of circumventing multidrug-resistant human leukemia cell line K562/A02 by fraction CⅡ from Naja naja Actra Venom

ZUO Chang-qing, LIN Zhen-tao1, KONG Tian-han1   

  1. Department of Pharmacology, Guangdong Medical College, Zhanjiang 524023, Guangdong, China;
    1Guangzhou Research Institute of Snake Venom, Guangzhou Medical College, Guangzhou 510182, Guangdong, China
  • Received:2005-07-06 Revised:2005-08-18 Published:2020-11-22

Abstract: AIM: To investigate the inhibitory effect of fraction C Ⅱ from Naja naja Actra Venom (FC Ⅱ NNAV) on multidrug-resistant human leukemia cell line K562/A02 and its mechanisms.METHODS: The cytotoxicity of FC ⅡNNAV on K562/A02 and k562 cells was measured by MTT assay.The protein expression of P-gp and Bcl-2 of K562/A02 was observed by flow cytometry. The activation of Caspase-3 was detected by colorimetric assay.RESULTS: FC ⅡNNAV had the inhibitory effect on K562/A02 and K562.The values of IC50 were 0.75±0.01 and 0.67±0.11 μg·ml-1, respectively.The expression of P-gp and Bcl-2 decreased after application of FC Ⅱ NNAV and Caspase-3 was activated by FC Ⅱ NNAV.CONCLUSION: FC ⅡNNAV has the inhibitory effect on K562/A02 and K562.FC ⅡNNAV can induce K562/A02 cell apoptosis through down-regulation expression of P-gp and Bcl-2 and activating Caspase-3.

Key words: snake venom, neoplasm, multidrug resistance, apoptosis, P-glycoprotein

CLC Number: